SenesTech, Inc., a biotechnology company based in Phoenix, Arizona, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3 to 4:00 p.m. Eastern time on October 4, 2024. The request, made in accordance with Rule 461 under the Securities Act of 1933, was submitted through a correspondence addressed to Jane Park at the SEC's Division of Corporation Finance, Office of Manufacturing. SenesTech has indicated that once the Registration Statement is declared effective, the company's counsel, Greenberg Traurig, LLP, should be orally notified. Thomas C. Chesterman, the Chief Financial Officer of SenesTech, signed the letter, acknowledging the company's understanding that the SEC's declaration does not preclude further action regarding the filing, nor does it absolve the company of its responsibility for the disclosure's adequacy and accuracy. The company also recognizes that it cannot use the SEC's declaration of effectiveness as a defense in any legal proceedings.

SenesTech, Inc., a biotechnology company based in Phoenix, Arizona, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3 to 4:00 p.m. Eastern time on October 4, 2024. The request, made in accordance with Rule 461 under the Securities Act of 1933, was submitted through a correspondence addressed to Jane Park at the SEC's Division of Corporation Finance, Office of Manufacturing. SenesTech has indicated that once the Registration Statement is declared effective, the company's counsel, Greenberg Traurig, LLP, should be orally notified. Thomas C. Chesterman, the Chief Financial Officer of SenesTech, signed the letter, acknowledging the company's understanding that the SEC's declaration does not preclude further action regarding the filing, nor does it absolve the company of its responsibility for the disclosure's adequacy and accuracy. The company also recognizes that it cannot use the SEC's declaration of effectiveness as a defense in any legal proceedings.